Basic Information
| RNALocate ID: | RLID:11003182 |
| RNA Symbol: | hsa-miR-455-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-455-5p |
| RNA ID: | miRBase:MIMAT0003150 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 25242326 |
| Tissue/Cell Line: | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells |
| Method: | Next-generation RNA sequencing |
| Description: | Although the miRNA distribution in exosomal fractions is clearly influenced by cellular miRNA abundance, we identified a subset of miRNAs that were discordantly distributed between cells and exosomes (false discovery rate [FDR] < 0.05; Tables S1B and S1C). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002392 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002393 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11003178 | Exosome | Pulmonary epithelial cell line (BEAS-2B) | 31520698 |
| RLID:11003179 | Exosome | Serum | 18589210 |
| RLID:11003180 | Exosome | Brain tissue | 23382797 |
| RLID:11003181 | Exosome | Plasma | 23663360 |
| RLID-D:11000158 | Exosome | Tongue tissue | |
| RLID-D:11000506 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-455-5p | Oral squamous cell carcinoma | MNDR-E-MI-51781 |
| MNDR | hsa-miR-455-5p | Large cell neuroendocrine cancer | MNDR-E-MI-51782 |
| MNDR | hsa-miR-455-5p | Medulloblastoma | MNDR-E-MI-51783 |
| MNDR | hsa-miR-455-5p | Small intestinal neuroendocrine tumor | MNDR-E-MI-51784 |
| MNDR | hsa-miR-455-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-51785 |
| MNDR | hsa-miR-455-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-51786 |
| MNDR | hsa-miR-455-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-51787 |
| MNDR | hsa-miR-455-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-51788 |
| MNDR | hsa-miR-455-5p | Her2-receptor positive breast cancer | MNDR-E-MI-51789 |
| MNDR | hsa-miR-455-5p | Small intestine cancer | MNDR-E-MI-51790 |
| MNDR | hsa-miR-455-5p | Prostate cancer | MNDR-E-MI-51791 |
| MNDR | hsa-miR-455-5p | Gastric cancer | MNDR-E-MI-51792 |
| MNDR | hsa-miR-455-5p | Alzheimer disease | MNDR-E-MI-51793 |
| MNDR | hsa-miR-455-5p | Intracranial aneurysm | MNDR-E-MI-51794 |
| MNDR | hsa-miR-455-5p | Esophageal carcinoma | MNDR-E-MI-51795 |
| MNDR | hsa-miR-455-5p | Dysautonomia familial | MNDR-E-MI-51796 |
| MNDR | hsa-miR-455-5p | Head and neck cancer | MNDR-E-MI-51797 |
| MNDR | hsa-miR-455-5p | Lewy body dementia | MNDR-E-MI-51798 |
| MNDR | hsa-miR-455-5p | Graves disease | MNDR-E-MI-51799 |
| MNDR | hsa-miR-455-5p | Leukemia | MNDR-E-MI-51800 |
| MNDR | hsa-miR-455-5p | Huntington disease | MNDR-E-MI-51801 |
| MNDR | hsa-miR-455-5p | Lung cancer | MNDR-E-MI-51802 |
| MNDR | hsa-miR-455-5p | Parkinson disease | MNDR-E-MI-51803 |
| MNDR | hsa-miR-455-5p | Basal-like breast cancer | MNDR-E-MI-51804 |
| MNDR | hsa-miR-455-5p | Neuroendocrine neoplasia | MNDR-E-MI-51805 |
| MNDR | hsa-miR-455-5p | Thyroid cancer | MNDR-E-MI-51806 |
| MNDR | hsa-miR-455-5p | Pancreatic cancer | MNDR-E-MI-51807 |
| MNDR | hsa-miR-455-5p | Malignant melanoma | MNDR-E-MI-51808 |
| MNDR | hsa-miR-455-5p | Nephroblastoma | MNDR-E-MI-51809 |
| MNDR | hsa-miR-455-5p | Colon cancer | MNDR-E-MI-51810 |
| MNDR | hsa-miR-455-5p | Colon adenocarcinoma | MNDR-E-MI-51811 |
| MNDR | hsa-miR-455-5p | Familial ovarian cancer | MNDR-E-MI-51812 |
| MNDR | hsa-miR-455-5p | Basal cell carcinoma | MNDR-E-MI-51813 |
| MNDR | hsa-miR-455-5p | Prostate adenocarcinoma | MNDR-E-MI-51814 |
| MNDR | hsa-miR-455-5p | Glioma | MNDR-E-MI-51815 |
| MNDR | hsa-miR-455-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-51816 |
| MNDR | hsa-miR-455-5p | Osteosarcoma | MNDR-E-MI-51817 |
| MNDR | hsa-miR-455-5p | Lung squamous cell carcinoma | MNDR-E-MI-51818 |
| MNDR | hsa-miR-455-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-51819 |
| MNDR | hsa-miR-455-5p | Lung adenocarcinoma | MNDR-E-MI-51820 |
| MNDR | hsa-miR-455-5p | Thyroid carcinoma | MNDR-E-MI-51821 |
| MNDR | hsa-miR-455-5p | Bladder urothelial carcinoma | MNDR-E-MI-51822 |
| MNDR | hsa-miR-455-5p | Carcinoma renal cell | MNDR-E-MI-51823 |
| MNDR | hsa-miR-455-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-51824 |
| MNDR | hsa-miR-455-5p | Clear cell renal cell carcinoma | MNDR-E-MI-51825 |
| MNDR | hsa-miR-455-5p | Large cell carcinoma | MNDR-E-MI-51826 |
| MNDR | hsa-miR-455-5p | Cholangiocarcinoma | MNDR-E-MI-51827 |
| MNDR | hsa-miR-455-5p | Lung small cell carcinoma | MNDR-E-MI-51828 |
| MNDR | hsa-miR-455-5p | Synovial sarcoma | MNDR-E-MI-51829 |
| MNDR | hsa-miR-455-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-51830 |
| MNDR | hsa-miR-455-5p | Hepatocellular carcinoma | MNDR-E-MI-51831 |
| MNDR | hsa-miR-455-5p | Familiar ovarian carcinoma | MNDR-E-MI-51832 |
| MNDR | hsa-miR-455-5p | Barrett's adenocarcinoma | MNDR-E-MI-51833 |
| MNDR | hsa-miR-455-5p | Hodgkin lymphoma | MNDR-E-MI-51834 |
| MNDR | hsa-miR-455-5p | Tonsil cancer | MNDR-E-MI-51835 |
| MNDR | hsa-miR-455-5p | Acute myelocytic leukemia | MNDR-E-MI-51836 |
| MNDR | hsa-miR-455-5p | Colorectal cancer | MNDR-E-MI-51837 |
| MNDR | hsa-miR-455-5p | Nasopharynx carcinoma | MNDR-E-MI-51838 |
| MNDR | hsa-miR-455-5p | Nasopharyngeal cancer | MNDR-E-MI-51839 |
| MNDR | hsa-miR-455-5p | Barrett's carcinogenesis | MNDR-E-MI-51840 |
| MNDR | hsa-miR-455-5p | HPV | MNDR-E-MI-51841 |
| MNDR | hsa-miR-455-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-51842 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | NCSTN | Homo sapiens | RR00986176 |
TOP